Physician's Weekly
JUNE 12, 2025
Food and Drug Administration (FDA) after the manufacturer, Church & Dwight Co., So far, no illnesses or serious injuries have been reported, CBS News said. More information Read the full recall notice at the U.S. health officials said. The recall was announced by the U.S. found the problem during testing, CBS News reported.
The Medical Futurist
JUNE 21, 2025
Compared to that, our hearing only processes 11 percent of information, while smell 3.5 Treating less serious ailments gets faster, more targeted and more efficient, while the means for curing more serious and life-altering illnesses improve. percent, touch 1.5 percent and taste 1 percent. Don’t you think that’s possible?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FDA Law Blog
OCTOBER 25, 2021
The regulatory uncertainty has ill?befitted In the PMA context, the statute permits FDA to withhold approval if manufacturing facilities do not conform to QSR requirements. FDA says inspections may be necessary if a device has “critical and/or novel manufacturing processes that may impact the safety and effectiveness of the device.”
FDA Law Blog
JUNE 12, 2023
As anyone familiar with pet (and other animal) food regulation knows, many states require premarket label review and approval and registration of the manufacturer/distributor and/or product for a fee. They have inspectors in the field everyday with eyes on the products, on the local manufactures, and on the distributors and retailers.
GeriPal
MAY 5, 2022
We talk with Nick and Meg about: Why hearing loss is important not just in geriatrics but also for those caring for seriously ill individuals. And when you think about that, they’re hearing pieces of the information and their brain is trying to make sense of it. How to screen for hearing loss. Eric: And how do we screen for it?
FDA Law Blog
MARCH 12, 2024
Koblitz — After years of silence from FDA on whether certain patents could be listed in the Orange Book, some manufacturers of drug and device combination products have had a rude awakening lately. Rather, the FTC questioned whether these patents meet the statutory and regulatory criteria for listing in the Orange Book.
GeriPal
MAY 8, 2025
We’ll discuss three recent clinical trials involving patients with serious illness, joined by our guests James Downar , Ali John Zarrabi , and Margaret Ross. We’re going to be talking about new research in psilocybin in serious illness. Margaret 22:45 So the eligibility was that they had to have a life threatening illness.
Expert insights. Personalized for you.
52 
Let's personalize your content